Thanks Bruce
@LifeSciVC. Time cannot move fast enough to bring this brave idea and prototype medicine to patients with AML. As a stem cell transplant physician, I am well calibrated to the challenge AML patients face. All learnings, insights and leaders at
@Amgen in ALL will be accessible to this amazing team of innovators.